%0 Journal Article
%T Benralizumab reduces blood basophil percentage and activation in vitro without eliciting degranulation.
%A Gil-Martínez M
%A Rodrigo-Muñoz JM
%A Lorente-Sorolla C
%A de Castro ZG
%A Mínguez P
%A Cañas JA
%A Valverde-Monge M
%A Bernaola J
%A Pinillos-Robles EJ
%A Betancor D
%A Fernández-Nieto M
%A Sastre J
%A Rodríguez-Nieto MJ
%A Del Pozo V
%J Allergy
%V 0
%N 0
%D 2024 Jun 6
%M 38841822
%F 14.71
%R 10.1111/all.16190